Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A1 | P13866 | 10/20 | 0.72 |
| ▸ | SLC5A2 | P31639 | 8/20 | 0.72 |
| ▸ | MAPT | P10636 | 4/20 | 0.72 |
| ▸ | SLC28A3 | Q9HAS3 | 3/20 | 0.72 |
| ▸ | HPGD | P15428 | 3/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.72 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.72 |
| ▸ | MEN1 | O00255 | 2/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.72 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.72 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.72 |
| ▸ | RELA | Q04206 | 2/20 | 0.72 |
| ▸ | GAA | P10253 | 2/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.72 |
| ▸ | THRB | P10828 | 2/20 | 0.72 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.72 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1938352 | 0.93 | SLC5A1 (0.84) | SLC5A1SLC5A2MAPTSLC28A3HPGD | |
| SCHEMBL6398347 | 0.91 | NFKB1 (0.74) | SLC5A1SLC5A2MAPTSLC28A3HPGD | |
| SCHEMBL1938569 | 0.90 | SLC5A1 (0.73) | SLC5A1SLC5A2MAPTSLC28A3HPGD | |
| SCHEMBL20281260 | 0.89 | SLC5A1 (0.68) | SLC5A1SLC5A2MAPTSLC28A3HPGD | |
| SCHEMBL2282039 | 0.86 | NFKB1 (0.83) | SLC5A1SLC5A2MAPTSLC28A3HPGD | |
| Asebogenin SCHEMBL4740064 | 0.85 | NFKB1 (0.88) | SLC5A1SLC5A2MAPTSLC28A3HPGD | |
| Phloretin SCHEMBL27910960 | 0.85 | SLC5A1 (0.93) | SLC5A1SLC5A2MAPTSLC28A3HPGD | |
| Phloretin SCHEMBL38131 | 0.85 | SLC5A1 (1.00) | SLC5A1SLC5A2MAPTSLC28A3HPGD | |
| Phloretin SCHEMBL1506325 | 0.85 | SLC5A1 (1.00) | SLC5A1SLC5A2MAPTSLC28A3HPGD | |
| SCHEMBL457127 | 0.84 | SLC5A1 (1.00) | SLC5A1SLC5A2MAPTSLC28A3HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023169995-A1 | SWEETENER COMPOSITIONS | FIRMENICH SA (CH) | 2023-09-14 | — | — | WO | disclosed |
| US-9328128-B2 | Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport | DUOPHOS (US) | 2016-05-03 | — | — | US | disclosed |
| US-20150080597-A1 | ARYLFLUOROPHOSPHATE INHIBITORS OF INTESTINAL APICAL MEMBRANE SODIUM/PHOSPHATE CO-TRANSPORT | DUOPHOS | 2015-03-19 | — | — | US | disclosed |
| US-8921343-B2 | Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport | DUOPHOS (US) | 2014-12-30 | — | — | US | disclosed |
| US-8431166-B2 | Composition comprising the extract of Anemarrhena asphodeloides Bunge or the compounds isolated from the same for preventing and treating lipid metabolism disorder | EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (KR) | 2013-04-30 | — | — | US | disclosed |
| US-8431166-B2 | Composition comprising the extract of Anemarrhena asphodeloides Bunge or the compounds isolated from the same for preventing and treating lipid metabolism disorder | EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (KR) | 2013-04-30 | — | — | US | disclosed |
| US-20130059822-A1 | Arylfluorophosphate Inhibitors of Intestinal Apical Membrane Sodium/Phosphate Co-Transport | DUOPHOS (US) | 2013-03-07 | — | — | US | disclosed |
| US-20120070515-A1 | Composition Comprising the Extract of Anemarrhena Asphodeloides Bunge or the Compounds Isolated from the Same for Preventing and Treating Lipid Metabolism Disorder | EWHA UNIVERSITY- INDUSTRY COLLABORATION FOUNDATION (KR) | 2012-03-22 | — | — | US | disclosed |
| US-20120070515-A1 | Composition Comprising the Extract of Anemarrhena Asphodeloides Bunge or the Compounds Isolated from the Same for Preventing and Treating Lipid Metabolism Disorder | EWHA UNIVERSITY- INDUSTRY COLLABORATION FOUNDATION (KR) | 2012-03-22 | — | — | US | disclosed |
| US-7777073-B2 | Topical delivery system for antiaging and skin whitening agents | BIODERM RESEARCH (US) | 2010-08-17 | — | — | US | disclosed |
| US-20090074691-A1 | Topical Delivery System for Antiaging and Skin Whitening Agents | BIODERM RESEARCH (US) | 2009-03-19 | — | — | US | disclosed |
| US-7427690-B2 | Multifunction “crown complexes” from amino acids and peptides for skin and hair restoration | BIODERM RESEARCH (US) | 2008-09-23 | — | — | US | disclosed |
| US-20070099886-A1 | Multifunction \"Crown Complexes\" from Amino Acids and Peptides for Skin and Hair Restoration | BIODERM RESEARCH (US) | 2007-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150080597-A1 | ARYLFLUOROPHOSPHATE INHIBITORS OF INTESTINAL APICAL MEMBRANE SODIUM/PHOSPHATE CO-TRANSPORT | SLC10A2, SLC34A2, SLC34A1 | SLC5A1 29/4885SLC5A2 31/4885MAPT 2467/4885 |
| US-20090074691-A1 | Topical Delivery System for Antiaging and Skin Whitening Agents | TYR, MMP17, MMP1 | SLC5A1 4606/4885SLC5A2 4510/4885MAPT 3248/4885 |
| US-20120070515-A1 | Composition Comprising the Extract of Anemarrhena Asphodeloides Bunge or the Compounds Isolated from the Same for Preventing and Treating Lipid Metabolism Disorder | FABP4, ACACB, LIPC | SLC5A1 1311/4885SLC5A2 852/4885MAPT 2597/4885 |
| US-20130059822-A1 | Arylfluorophosphate Inhibitors of Intestinal Apical Membrane Sodium/Phosphate Co-Transport | SLC10A2, SLC34A2, SLC34A1 | SLC5A1 29/4885SLC5A2 31/4885MAPT 2467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.